missing translation for 'onlineSavingsMsg'
Learn More
Learn More
IBA Lifesciences CD3 Fab-TACS™ Gravity Kit
IBA Lifesciences™ CD3 Fab-TACS™ Gravity Kit is for reversible cell isolation delivering label-free target cells.
Brand: IBA Lifesciences 6-3201-004
This item is not returnable.
View return policy
Description
- The kit allows the selection of CD3+ T cells directly from whole blood.
- CD3 Fab-Strep, human
- Buffer CI (10x)
- Biotin stock solution
- Fab-TACS™ Gravity Adapter
- Fab-TACS™ Flow Restrictor
- The Fab-TACS™ Gravity column is filled with a Strep-Tactin™ coated matrix made of cell-grade agarose.
- Strep-tagged Fab fragments (Fab-Streps) specifically bind to the matrix.
- Subsequently, whole blood or other blood preparations pass through the column.
- Target cells adhere to the matrix based on the exclusive binding of the Fab-Strep to the target cell.
- Non-target cells are efficiently washed away.
- In a final step, the addition of biotin causes the elution of the target cells and the Fab-Streps.
- After elution, the Fab-Streps self-dissociate from the cell surfaces.
- The label-free authentic target cells are now ready for further downstream applications.
Specifications
Non-magnetic Cell Isolation Kit | |
Human Whole Blood | |
60 mL whole blood |
2°C to 8°C | |
Isolation of label-free cells | |
4 Columns, Human |
Safety and Handling
Product Identifier
Signal Word
Hazard Category
Hazard Statement
Precautionary Statement
Supplemental information
- CD3 Fab-TACS Gravity Isolation Kit,Human single ma rker,4 columns,capacity 15ml whole blood each
Signal Word
- Warning
Hazard Category
- LONG-TERM AQUATIC HAZARD Chronic 3
Hazard Statement
- H412-Harmful to aquatic life with long lasting effects.
Precautionary Statement
- P273-Avoid release to the environment.
Supplemental information
- MIXTURE LIST-Contains : sodium azide
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction